Cargando…
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
BACKGROUND AND OBJECTIVE: Dopamine plays an important role in the disease pathology of Parkinson’s disease and schizophrenia. These two neuropsychiatric disorders represent disease end points of the dopaminergic spectrum where Parkinson’s disease represents dopamine deficit and schizophrenia represe...
Autores principales: | Gupta, Ashish Kumar, Pokhriyal, Ruchika, Das, Uddipan, Khan, Mohd Imran, Ratna Kumar, Domada, Gupta, Rishab, Chadda, Rakesh Kumar, Ramachandran, Rashmi, Goyal, Vinay, Tripathi, Manjari, Hariprasad, Gururao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650621/ https://www.ncbi.nlm.nih.gov/pubmed/31410011 http://dx.doi.org/10.2147/NDT.S205550 |
Ejemplares similares
-
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Evaluation of Serum Apolipoprotein E as a Potential Biomarker for
Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease
Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary
Study
por: Gupta, Ashish Kumar, et al.
Publicado: (2018) -
2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Chemotherapy Resistance in Advanced Ovarian Cancer Patients
por: Pokhriyal, Ruchika, et al.
Publicado: (2019) -
Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson’s Disease and Schizophrenia [Corrigendum]
Publicado: (2022)